Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K P Anderson

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Journal of Virology|April 1, 1980
Characterization of herpes simplex virus type 1 RNA present in the absence of de novo protein synthesisK P Anderson, R H Costa, L E Holland, et al.
Journal of Virology|February 1, 1980
Isolation and translation of mRNA encoded by a specific region of the herpes simplex virus type 1 genomeK P Anderson, L E Holland, B H Gaylord, et al.
Antisense & Nucleic Acid Drug Development|June 4, 1999
Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotidesV Brown-Driver, T Eto, E Lesnik, et al.
Journal of Cardiovascular Electrophysiology|July 21, 1999
Distinctive RR dynamics preceding two modes of onset of spontaneous sustained ventricular tachycardia. (ESVEM) Investigators. Electrophysiologic Study Versus Electrocardiographic MonitoringK P Anderson, V Shusterman, B Aysin, et al.
Pacing and Clinical Electrophysiology : PACE|April 6, 2000
Defibrillators in nonischemic cardiomyopathy treatment evaluationA Kadish, R Quigg, A Schaechter, et al.
Antiviral Research|November 1, 1988
Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatmentE H Fennie, Y S Lie, M A Low, et al.
Virology|March 1, 1991
Endogenous origin of defective retroviruslike particles from a recombinant Chinese hamster ovary cell lineK P Anderson, M A Low, Y S Lie, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)G B Mulamba, A Hu, R F Azad, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1993
Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early regionR F Azad, V B Driver, K Tanaka, et al.
IEEE Transactions on Bio-Medical Engineering|February 1, 1993
Criteria for local myocardial electrical activation: effects of electrogram characteristicsK P Anderson, R Walker, M Fuller, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Journal of Virology|April 1, 1980
Characterization of herpes simplex virus type 1 RNA present in the absence of de novo protein synthesisK P Anderson, R H Costa, L E Holland, et al.
Journal of Virology|February 1, 1980
Isolation and translation of mRNA encoded by a specific region of the herpes simplex virus type 1 genomeK P Anderson, L E Holland, B H Gaylord, et al.
Antisense & Nucleic Acid Drug Development|June 4, 1999
Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotidesV Brown-Driver, T Eto, E Lesnik, et al.
Journal of Cardiovascular Electrophysiology|July 21, 1999
Distinctive RR dynamics preceding two modes of onset of spontaneous sustained ventricular tachycardia. (ESVEM) Investigators. Electrophysiologic Study Versus Electrocardiographic MonitoringK P Anderson, V Shusterman, B Aysin, et al.
Pacing and Clinical Electrophysiology : PACE|April 6, 2000
Defibrillators in nonischemic cardiomyopathy treatment evaluationA Kadish, R Quigg, A Schaechter, et al.
Antiviral Research|November 1, 1988
Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatmentE H Fennie, Y S Lie, M A Low, et al.
Virology|March 1, 1991
Endogenous origin of defective retroviruslike particles from a recombinant Chinese hamster ovary cell lineK P Anderson, M A Low, Y S Lie, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)G B Mulamba, A Hu, R F Azad, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1993
Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early regionR F Azad, V B Driver, K Tanaka, et al.
IEEE Transactions on Bio-Medical Engineering|February 1, 1993
Criteria for local myocardial electrical activation: effects of electrogram characteristicsK P Anderson, R Walker, M Fuller, et al.
Pageof 9